E2F1 and breast cancer: To investigate the prevalence of TEs in breast cancer-associated TFBSs, we mapped the genome-wide binding sites for C/EBPβ, E2F1 and MYC in MCF7 breast cancer cells by re-analysing publicly available chromatin immunoprecipitation sequencing (ChIP-seq) datasets.